These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8859939

  • 1. Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats.
    Vacher E, Richer C, Fornes P, Clozel JP, Giudicelli.
    J Cardiovasc Pharmacol; 1996 May; 27(5):686-94. PubMed ID: 8859939
    [Abstract] [Full Text] [Related]

  • 2. Effects of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats.
    Vacher E, Richer C, Giudicelli JF.
    J Hypertens; 1996 Nov; 14(11):1341-8. PubMed ID: 8934363
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
    Nakamura Y, Ono H, Frohlich ED.
    Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
    Karam H, Heudes D, Bruneval P, Gonzales MF, Löffler BM, Clozel M, Clozel JP.
    Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
    [Abstract] [Full Text] [Related]

  • 11. The antihypertensive efficacy of the novel calcium antagonist mibefradil in comparison with nifedipine GITS in moderate to severe hypertensives with ambulatory hypertension.
    Lacourcière Y, Poirier L, Lefebvre J, Archambault F, Dalle Ave S, Ward C, Lindberg E.
    Am J Hypertens; 1997 Feb; 10(2):189-96. PubMed ID: 9037327
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
    Xia QG, Reinecke A, Dorenkamp M, Storz C, Bitterling H, Penz S, Cleutjens J, Daemen MJ, Simon R, Unger T.
    Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular effects of mibefradil in hypertensive patients with obstructive sleep apnea.
    Heitmann J, Grote L, Knaack L, Köhler U, Hinder M, Peter JH.
    Eur J Clin Pharmacol; 1998 Jun; 54(9-10):691-6. PubMed ID: 9923569
    [Abstract] [Full Text] [Related]

  • 15. Differential properties of mibefradil in hypertension and angina.
    Kobrin I.
    J Hypertens Suppl; 1997 Dec; 15(5):S33-40. PubMed ID: 9481614
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats.
    Ueda M, Masui M, Kawakami M, Matsunaga K, Gemba T, Ninomiya M, Nakano A, Torii M, Adachi I, Ito H.
    Arzneimittelforschung; 1993 Dec; 43(12):1291-303. PubMed ID: 8141816
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.